ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.

Rituparna Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.